VERA (Vera Therapeutics) ROE % Adjusted to Book Value: -15.17% (As of Mar. 2026)


VERA Vera Therapeutics Inc VERA
34 GF Score
Price $43.33
! 3 Warning Signs
View Full Analysis

What is Vera Therapeutics ROE % Adjusted to Book Value?

Vera Therapeutics VERA +2.04% 34 ROE % Adjusted to Book Value is -15.17% as of Mar. 2026. GuruFocus rates VERA with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Vera Therapeutics's ROE % for the quarter that ended in Mar. 2026 was -87.69%. Vera Therapeutics's PB Ratio for the quarter that ended in Mar. 2026 was 5.78. Vera Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -15.17%.

Vera Therapeutics ROE % Adjusted to Book Value Related Terms

Vera Therapeutics ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Vera Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vera Therapeutics ROE % Adjusted to Book Value Chart

Vera Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 -17.37 -16.00 -9.62 -8.49

Vera Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.00 -19.01 -15.93 -12.17 -15.17

VERA vs RARE, IRON, QURE: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Vera Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vera Therapeutics ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vera Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vera Therapeutics's ROE % Adjusted to Book Value falls into.


VERA
34GF Score
Vera Therapeutics Inc VERA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vera Therapeutics ROE % Adjusted to Book Value Calculation

Vera Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-50.71% / 5.97
=-8.49%

Vera Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-87.69% / 5.78
=-15.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -15.17% mean?
Vera Therapeutics (VERA) has a ROE % Adjusted to Book Value of -15.17% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Vera Therapeutics and its competitors.
Is Vera Therapeutics' ROE % Adjusted to Book Value too high?
Vera Therapeutics' current ROE % Adjusted to Book Value is -15.17%. Overall, Vera Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Vera Therapeutics' ROE % Adjusted to Book Value compare to RARE and IRON?
Vera Therapeutics' ROE % Adjusted to Book Value of -15.17% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Vera Therapeutics and its competitors. Vera Therapeutics's current ROE % Adjusted to Book Value is -15.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vera Therapeutics stock overvalued right now?
Vera Therapeutics (VERA) has a current ROE % Adjusted to Book Value of -15.17%. The current ROE % Adjusted to Book Value is -15.17%. Vera Therapeutics' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Vera Therapeutics (VERA), the current ROE % Adjusted to Book Value is -15.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vera Therapeutics Business Description

Address 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA, USA, 94005
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
34GF Score

Get the complete analysis for VERA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.33
Price